Production and characterization of recombinant factor VIIi
Klein, U.
Seminars in Hematology 28(2 Suppl 1: 17-21
1991
ISSN/ISBN: 0037-1963 PMID: 1908121 Document Number: 372565
Document emailed within 1 workday
Related Documents
Lee, C.A.; Owens, D.; Bray, G.; Giangrande, P.; Collins, P.; Hay, C.; Gomperts, E.; Schroth, P.; Barrowcliffe, T. 1999: Pharmacokinetics of recombinant factor VIIi (recombinate) using one-stage clotting and chromogenic factor VIIi assay Thrombosis and Haemostasis 82(6): 1644-1647Fijnvandraat, K.; Berntorp, E.; ten Cate, J.W.; Johnsson, H.; Peters, M.; Savidge, G.; Tengborn, L.; Spira, J.; Stahl, C. 1997: Recombinant, B-domain deleted factor VIII (r-VIII SQ): pharmacokinetics and initial safety aspects in hemophilia A patients Thrombosis and Haemostasis 77(2): 298-302
Mahasandana, C.; Suvatte, V.; Püng-amritt, P.; Tuchinda, S. 1979: Von Willebrand's disease: studies of platelet functions, factor VIII procoagulant activity (F VIII C) and factor VIII-related antigen (F VIII RAg) in three families Southeast Asian Journal of Tropical Medicine and Public Health 10(2): 243-247
Brown, J.E.; Carton, C.L.; Hougie, C. 1981: The effect of naturally occurring antibodies to factor VIIi on an immunoradiometric assay for factor VIIi coagulant antigen. Observation on a cross-reacting material-positive (CRM+) hemophiliac with a factor VIIi inhibit Journal of Laboratory and Clinical Medicine 97(1): 65-71
Takahashi, I.; Furuta, M.; Mizuno, S.; Takamatsu, J.; Kamiya, T. 1993: Effect of substrate and diluent for factor VIIi activity in highly purified factor VIIi concentrate and patient plasma infused factor VIIi concentrate Rinsho Byori. Japanese Journal of Clinical Pathology 41(7): 825-830
Muntean, W. 1984: Purified complex of factor VIII coagulant moiety and phospholipid: high factor VIII coagulant activity in factor VIII inhibitor plasma Wiener Klinische Wochenschrift 96(22): 829-832
Tusell, J.M. 1993: Recombinant factor VIIi Sangre 38(2): 139-142
Tran, T.H.; Duckert, F. 1983: Dissociation of factor VIIi procoagulant antigen VIII:CAg and factor VIIi related antigen VIIIR:Ag by EDTA - influence of divalent cation on the binding of VIII:CAg and VIIIR:Ag Thrombosis and Haemostasis 50(2): 547-551
Holloway, C.J. 1994: Applications of recombinant DNA technology in the production of glycosylated recombinant human granulocyte colony stimulating factor European Journal of Cancer 30a Suppl 3: S2-S6
Fournel, M.A. 1991: Preclinical and in vitro studies of recombinant factor VIIi Seminars in Hematology 28(2 Suppl 1: 22-26
Berntorp, E. 1997: Second generation, B-domain deleted recombinant factor VIII Thrombosis and Haemostasis 78(1): 256-260
Hilgartner, M.W. 1991: The need for recombinant factor VIII: historical background and rationale Seminars in Hematology 28(2 Suppl 1: 6-9
Briseid, G.; Arntzen, F.C. 1995: Factor VIIi preparation produced by recombinant DNA-technology is approved in Norway Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 115(15): 1849-1851
Eis-Hübinger, A.M.; Sasowski, U.; Brackmann, H.H.; Kaiser, R.; Matz, B.; Schneweis, K.E. 1996: Parvovirus B19 DNA is frequently present in recombinant coagulation factor VIIi products Thrombosis and Haemostasis 76(6): 1120
Schwartz, R.S.; Rousell, R.H. 1991: A summary of the world-wide clinical investigations of recombinant factor VIII Seminars in Hematology 28(2 Suppl. 1): 53-54
Yoshioka, A.; Shima, M.; Nishino, M.; Yoshikawa, N.; Fukui, H. 1987: In vitro characterization of various factor VIII concentrates Arzneimittel-Forschung 37(7): 753-756
Bukurestliev, A.; Angelova, Z.; Lissitschkov, T. 1976: Production of an enriched factor VIIi reagent Folia Haematologica 103(5): 742-745
Lollar, P. 1999: Characterization of factor VIIi B-cell inhibitory epitopes Thrombosis and Haemostasis 82(2): 505-508
Kröniger, A.; Kumpe, A.; Wormsbächer, W.; Herchenhahn, B. 1982: Factor VIIi concentrates. Problems and protein chemistry characterization Die Medizinische Welt 33(28): 1027-1033
Hoyer, L.W.; Qian, J. 2000: Characterization of the immune response to factor VIIi using hemophilia A* mice Haematologica 85(10 Suppl): 100-102